served as the president of the International Organization for Mycoplasmology, from 1992 to 1994. Since 2004, when HLB was identified in Brazil, this destructive disease of citrus has become Bové’s major occupation in Brazil and other affected countries. Dr. Bové has over 250 publications in international refereed journals. He holds a Ph.D. from the University of Paris, France.
Paul Citron retired from Medtronic Inc. in 2003 as Vice President of Technology Policy and Academic Relations. In that position he was responsible for identifying and addressing public policy matters that affect medical technology innovation and for working with leading biomedical engineering institutions. He is currently an adjunct faculty member at University of California (UC), San Diego and UC Riverside, Department of Bioengineering. Mr. Citron was elected to the National Academy of Engineering in 2003; he was elected as a Founding Fellow of the American Institute of Medical and Biological Engineering in 1993; he received the American College of Cardiology Governor’s Award for Excellence twice; and was inducted as a Fellow of the Medtronic Bakken Society in 1980. He was voted the Institute of Electrical and Electronics Engineers (IEEE) Young Electrical Engineer of the Year in 1979. He has authored numerous publications including refereed articles in the IEEE Transactions on Rehabilitation Engineering journal; and holds several medical device pacing-related patents. In 1980, he was given Medtronic’s "Invention of Distinction" award for his role as co-inventor of the tined pacing lead. Mr. Citron has served on many management committees and advisory boards, including the Biomedical Engineering Materials and Applications Roundtable and the National Research Council, from 2001 to present. Mr. Citron holds a M.S. in Electrical Engineering from the University of Minnesota.
Philip W. Miller currently serves as the Vice President of US Product Management in the Monsanto US Commercial Organization. He is responsible for product portfolio planning and execution throughout the product life cycle, including gathering and prioritizing product and customer requirements, defining the product vision, and working closely with research and development, corporate strategy, sales, marketing and support groups. Dr. Miller joined Monsanto in 1994 and has held numerous roles in the Monsanto Technology organization spanning Chemical Discovery and Biotechnology Research and Development. Key roles include Director of Biotechnology Crop Yield Enhancement and Crop Genomics research, Monsanto/Ceres Research Collaboration Lead, Director of the Monsanto Connecticut Research Center and Biotechnology Corn Pipeline Strategy Lead. Prior to his current role he served as Vice President of US Technology Development. Dr. Miller served on US Department of Agriculture, National Institute of Health, and National Science Foundation sponsored review panels, and as a scientific reviewer for numerous journals. He is the inventor on numerous patents and the author of seventeen scientific papers in journals including Plant Molecular Biology and book chapters. Dr. Miller earned his Ph.D. in Biochemistry and Molecular Biology from the University of Florida.
Lowell R. Nault is a Professor Emeritus at the Ohio State University. He has extensive research experience in the transmission of plant pathogens by arthropods and in the evolutionary biology of vectors and plant pathogens. He has worked in collaboration with US Department of Agriculture entomologists on a spectrum of problems ranging from molecular to landscape ecology, especially maize vectors and pathogens. Dr. Nault has authored well over 100 peer-reviewed articles and co-edited the text The Leafhoppers and Planthoppers. Dr. Nault is a fellow